secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001104659-25-045050
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elutia terminates LeMaitre distribution deal, moves to direct cardiovascular sales
--------------------------------------------------------------------------------

- Termination of distribution agreement with LeMaitre Vascular for ProxiCor, VasCure, Tyke products in the U.S.
- Appoints Dwayne Montgomery as Head of Cardiovascular; recruits 26 independent sales reps for new direct sales unit.
- Expects ~80% gross margins and top-line growth; 2024 cardiovascular product sales were $2.9M (12% of revenue).
- No early termination penalties incurred; transition to direct sales has commenced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465925045050/0001104659-25-045050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465925045050/tm2514183d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-045050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer